Tag Archives: EMD Serono

October, 2018

December, 2017

  • 27 December

    HTG Molecular Diagnostics Expands Collaboration with Merck KGaA

    TUCSON, Ariz. and DARMSTADT, Germany, Dec. 26, 2017 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications today announced a new Master Collaboration Agreement for translational programs with Merck KGaA, Darmstadt, Germany, a leading science and technology company. The Master Collaboration …

May, 2017

November, 2016

March, 2016

  • 2 March

    Merck KGaA Initiates Phase 3 Study of its Humira Biosimilar

    DARMSTADT, Germany, March 2, 2016 /PRNewswire/ — Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the initiation of a global phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This milestone is a strong reflection of Merck KGaA, Darmstadt, Germany’s progress …

May, 2015

  • 12 May

    FDA Fast Tracks Merck KGaA’s Pancreatic Cancer Candidate

    The US Food and Drug Administration (FDA) has granted Fast Track designation to Merck KGaA and partner Threshold Pharmaceuticals’ investigational pancreatic cancer drug. The companies won Fast Track status for the development of evofosfamide, administered in combination with gemcitabine, for the treatment of previously untreated patients with metastatic or locally …